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The modern agricultural industry has been highly effective in the implemen-
tation of productive new technologies that provide more food, shelter, and
industrial materials for an expanding world population. Agricultural output
needed to produce an abundant food supply for nations where economies and
distribution systems are adequate is currently achieved on approximately six
million square miles of cultivated land, the same land use as in 1950, despite
a doubling in world population throughout this period. Such expanding pro-
ductivity, on constant or even diminishing agricultural land, is an essential
component of the sustainable agricultural system we all hope to develop. It can
only be achieved through continued scientific discovery to improve germplasm
and production practices throughout the world. There is no greater opportunity
today to accomplish this than through the application of biotechnology.
Increased global information exchange, international trade, and rapid inno-
vation in many areas of technology — especially biotechnology — are now
contributing to an evolution in the world agricultural industry, through which
substantial enhancement in our industry will occur much faster than ever
before. We will see more rapid improvement and global distribution of germ-
plasm and production practices, and we must prepare to deal with entirely
novel applications for agricultural land use. More so than any previous agri-
cultural technology infusion, biotechnology will impact all elements of the
industry, all associated industries, and all of interfacing society. The increased
speed and the extreme breadth of current change make this a particularly
unsettling time. Now, as never before, there is need for industry, academia, and
consumer interests to cooperate in the identification and management of issues
generated by this new technology. We must deal with new laws and regulations,
new products and industry practices, and entirely new agricultural uses that
will emerge as the potential of biotechnology is realized.
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Two circumstances are important in considering the magnitude of the situa-
tion we now face. First is the exceptional power of biotechnology to enable
rapid and precise manipulation of plant and animal genetics in ways that were
never previously feasible. Second, the application of biotechnology to other
industries beyond agriculture ensures that a massive level of research and
development expenditure will continue to fuel improvement in biotechnical
skills for the foreseeable future. Available resources for continued research
and technology development will be well above the historically low levels of
funding that have been targeted solely toward agriculture, and advances in
other industries will significantly contribute toward the rate of progress in our
own industry.
In this presentation I will discuss the breadth of the enabling technology,
its management through the intellectual property system, and the effects we
should anticipate as our industry adjusts to a more rapid pace in new product
development.
THE TECHNOLOGY
Biotechnology enables the precise alteration of metabolic processes of living
organisms to achieve novel outcomes. Advances in this field have relied upon
broad innovation in our understanding and manipulation of living materials,
which is achieved through the sciences of molecular and cellular biology.
Molecular biology is the study and manipulation of DNA, which is the common
“blueprint” of all living organisms. Such strong similarities exist in the char-
acter of DNA from all life forms that a common technology base is broadly
applicable toward gene discovery, gene mapping and tracking, and even the
genetic engineering of diverse microbial, plant, and animal systems. Cell
biology, also an integral aspect of biotechnology, is essentially the study of
structure and function of living cells. Like molecular biology, many principles
of cell biology can be generalized across species.
The necessary laboratory equipment and intellectual skills needed for
research in molecular and cellular biology have evolved dramatically over the
past two decades, and essential capabilities are already in place in most of the
world’s major academic and industrial centers worldwide, including not only
those which focus solely on agriculture, but other industries as well. Because
of the common interest in the application of molecular and cellular biology to
the health care, chemical, and other high-value industries, research and devel-
opment advances toward agricultural objectives will be furthered by discoveries
from outside our field. For example, molecular breeding technology, now
widely used to facilitate new crop development, continues to benefit greatly
from human genome mapping efforts. In addition, the refinement of gene map-
ping technology will contribute to our increased understanding of the existing
mechanisms by which plants and animals adapt to, and deal with, their envi-
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ronments, leading to new opportunities to engineer crop improvements in years
ahead. However, it is the transfer of genetic information from one organism to
another, even across species boundaries, that represents the most powerful new
opportunity for the improvement of plants and animals.
Many schemes have been developed for gene transfer to live organisms
and much of the technology is applicable toward any living cell, regardless of
species. While plant sciences have often followed the advancement of other
industries due to greater financial resources being directed toward fields such
as health care, the engineering of plants has progressed considerably faster than
comparable efforts in animals or humans because of practical and social con-
siderations. Gene delivery to all major plant species has already been achieved,
and the rate of continuing progress in refining crop gene delivery technology is
dramatic. With such powerful enabling technology in hand, our industry is now
turning to issues of new product development.
EVOLUTION OF THE AGRICULTURAL INDUSTRY
We are currently in the midst of an evolution in agriculture, provoked by the
maturation of biotechnology from the stage of concept development to appli-
cation. It is practical to view this evolution in three phases, each spanning
approximately a decade. The process began in earnest with a period of concept
evaluation and enabling technology development during the 1980s. This was
followed by a transition from technology development to early product devel-
opment, which is now underway. The evolution will continue, following the
turn of the next century, with more extensive product development, which will
lead to new agricultural applications and dramatic industry expansion.
The 1980s was an extraordinary period of technology enablement during
which biotechnical methods were generated for gene identification, gene
cloning and characterization, and for the delivery of genes to plants and
animals. Hundreds of millions of new dollars were infused into agricultural
research — much of it from the private sector — without any immediate
financial return through sale of products. It was indeed fortunate for our
progress in this emerging field that private sector funding was available, since
the early technology development was very costly and occurred as federal
research support began to decline. With many of the new technologies now
on line, the industry is increasing its focus on product-oriented research, while
continuing to refine essential aspects of enabling technology for the future.
Although marketable products were not generated during the 1980s, a signifi-
cant outcome from that period of discovery was intellectual property. The past
decade was not unlike the land rush of the past century, and many claims were
staked — large and small — that will shape the development of the industry
through the ongoing transition.
The agricultural industry in the 1990s will be dominated by a transition from
biotechnology development toward product and market development. We are
now in the midst of this change, with the first of the new products reaching the
marketplace in launches of unprecedented scope. Insect resistant cotton and
corn, herbicide resistant crops, and other early products have all been released
to a very receptive marketplace. Continued product success will ultimately
depend on the level of consistent value delivered to the consumer, but all
current indications show that new and faster product development will be a
major benefit to our industry. Years of research and product testing have gone
into each of the products now reaching the market, and the first revenues from
actual product sales are being welcomed by industry investors. However, the
development of those new products has further revealed peripheral industry
issues that result from the use of biotechnology. The creative revision of market
paradigms to enable sufficient value capture from novel products must now be
undertaken.
Following the turn of the century, the third decade of this evolution will be
characterized by more complex product development and significant com-
mercial expansion. We will watch value shift away from classical agricultural
chemical inputs toward more versatile crop and animal genetics. Industry
consolidation will continue through alliances and acquisitions, and the trend
toward vertical integration will escalate to enable more effective product
management and value capture. Many of the small companies that pursued
technology development in the past will have insufficient resources to move
products to market in a timely way, and many will close or be acquired by
larger firms. Companies of greater size and resources will adapt to the changing
environment, new production and marketing strategies will be established, and
entirely new business areas will be opened to exploit agricultural technology.
Among the key elements shaping these industry adaptations to the new tech-
nology will be ownership and control of new technologies and resulting prod-
ucts. While various commercial practices will contribute to such control, there
will be a strong influence from the patent system.
INTELLECTUAL PROPERTY IN AGRICULTURE
The generation of biotechnology skill has been very costly, and the application
of the new technology will entail higher costs in shorter research and develop-
ment cycles than historically practiced in agriculture. Government and foun-
dation support to finance this technology over the past decade has been very
limited. Increasing budget pressures in the federal government will make basic
and discovery research dollars increasingly scarce. The situation is ironic: time
frames in the enhancement of agricultural productivity are long, which is a
detraction to industry, but benefits are seen across society. Government expen-
ditures toward the enhancement of agricultural productivity have also his-
torically provided an exceptionally strong societal return. However, we are
facing a period where the continued development of agricultural productivity
will fall increasingly on private industry. For effective implementation of bio-
technology, product value must be more reliably captured to reimburse even
early stage researchers, or the product development pipeline will be diminished.
As has been demonstrated in all other technology-dependent industries, patent
law provides a mechanism to capture value when products are delivered to
consumers. That value is then distributed to contributors along the
development path.
A “patent” is a legal provision that provides an exclusive right to inventors
for a limited period of time to “make, use, or sell” their discovery in return for
releasing the knowledge of their invention to the general public. The patent
system has served many other industries well in stimulating research, encourag-
ing product development, and enabling the controlled distribution of products
to consumers. Patents are neither new or untested in agriculture, yet their
increased application to agricultural products must receive a much greater
emphasis in years ahead. Acceptance of a stronger intellectual property system
in agriculture has been slow.
Plant “certificate” protection was first offered with the Plant Patent Act
(PPA) of 1930, when breeders were given the opportunity to protect asexually
propagated crops developed through their breeding programs. Certificate pro-
tection was further extended in 1970 with the Plant Variety Protection Act
(PVPA), which covered sexually propagated crops. However, an intriguing
exclusion of a small class of crops — known as the “soup vegetables,” which
included okra, carrots, celery, tomatoes, peppers, and cucumbers — provides a
useful lesson for our current transition. The soup vegetable exclusion from the
PVPA resulted from a concerted lobbying effort by an industry sector that feared
proprietary protection would inhibit research and lead to increased vegetable
costs. In practice over the following decade, however, the protected crops
were the subject of increased research and development, with resulting yield
and quality enhancement without unacceptable price increases. In 1980, an
amendment to the PVPA was passed in which certificate protection was ex-
tended to cover the previously excluded soup vegetables. The lesson learned
through a decade of practical experience was one that had already been learned
in other industries: effective proprietary protection serves both the agricultural
industry and consumers by enabling equitable value distribution for product
innovations.
Proprietary protection for crops and animals was further extended when it
was determined that utility patent law, which is distinct from the PVPA, can be
applied to living organisms. Utility patents address products or processes that
are novel, non-obvious, have a defined utility, and are clearly described to the
general public, rather than maintained as trade secrets. The extension of utility
patent law to engineered plants and animals came about through two landmark
court rulings. In Chakrabarty v. Diamond (1980) it was determined that specific
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claims covering engineered oil-degrading bacteria were allowable under utility
patent law, because significant human intervention was required to generate
the product. This case first clarified that newly created living materials were to
be considered patentable products under utility patent law. The relevance to
agriculture was further extended in a second case, ex parte Hibberd (1985),
where it was determined that corn varieties with enhanced amino acid profiles
were patentable under utility patent law in addition to what PVPA protection
otherwise afforded. The effect of those two rulings was a dramatic escalation of
patent filings addressing all aspects of biotechnology. The applications cover
many now routine processes such as the use of DNA markers to streamline
breeding programs, technologies to make and transfer genes, and the resulting
engineered plants, seeds, and transgenic animal products from biotechnology.
Many early biotechnology patents have been issued, but still more remain
under prosecution. Concerns have been raised by various parties over the
number of new patents and the nature of claims that have emerged, based on
fears that agricultural biotechnology patents might impede research and delay
future product development. The current concerns are not unlike those which
led to the soup vegetable exclusion from the PVPA of 1970. Once again, we
can expect to find those fears to be unfounded. Research is proceeding in
both academia and industry at a rapid pace, and there has been no effort from
industry to extract value from research licenses to academia for the new tech-
nology. Indeed, many of the dominant patents in biotechnology are controlled
by academic institutions, and license revenues are contributing support for
academic research programs. Industry is effectively adjusting to the requirement
for patent licenses, and launches of valuable new products have been initiated
without inappropriate deterrence from licensing or litigation. The global
management of patents is far more unsettled, and it will be many years before
consistency emerges, particularly in nations that have not historically protected
intellectual property.
The experience from other technology arenas is being followed in biotech-
nology — early patents addressed broad enabling concepts; later inventions are
considerably more limited in scope. This is due to the requirement for novelty
in inventions, and as technologies mature it becomes more difficult to achieve
substantial advances that previously have not been disclosed to the public. The
outcome of this maturation process is that broad patents influence industry
development in the early years, while the more limited patents sustain long-
term product advancement of the industry. What is unusual in agricultural
biotechnology is that many of the most powerful patent applications, filed
early in the last decade, still remain under prosecution due to lengthy delays
imposed by prosecution backlogs and patent interference proceedings. These
dominating patents will have strong influence on the shaping of our industry
over the next two decades.
CAPTURING VALUE FROM BIOTECHNOLOGY
Genetic engineering of plants and animals is now well underway, with the
essential technology components in hand to develop real products. Gene design
and delivery technologies continue to be refined, useful genes for agronomic
and production traits are being unveiled in increasing numbers, and product
development is now the primary goal of our industry. However, the emergence
of the first new products presents a series of complex issues to the industry
regarding marketing and value capture.
The agricultural industry has historically been comprised of distinct seg-
ments including seed providers, growers, processors, distributors, and
consumer outlets. We have generally relied on the passage of commodity
materials from the farm, through processors, and on to consumers in distinct
steps that capture increasing incremental value as the refined agricultural
materials approach the end-user. A modern trend toward larger farming
operations and vertical integration, combining processing and distribution,
has been driven to date by economies of scale and other efficiencies provided
by channeled flow of materials through a controlled development pathway.
However, as biotechnology adds increasing value directly to germplasm, it will
catalyze a series of changes in industry value-capture paradigms, which will
lead to a more comprehensive transition toward identity preservation of crops
from seed to consumer.
For agriculture to be successful, products and services must have both a tan-
gible value and a mechanism to capture and return that value to product and
service providers. It is common to exchange value at the farm gate through sale
of germplasm and chemicals to growers at the processor level, where growers
receive compensation for their agricultural produce in return for deliverables to
the processor, and at the level of end-users, where processors and distributors
receive monetary value from consumers. Biotechnology is now promoting the
shift of a substantial component of crop value directly into the germplasm, but
this comes at a substantial development expense. Herbicide resistance, pest and
pathogen resistance, and various other traits of value to growers, processors, or
consumers are already entering the marketplace in the form of new germplasm.
These first product examples each involve genes encoding relatively simple,
single-gene traits. The traits now being delivered are conceptually consistent
with traits which have current market value. However, new mechanisms must
be devised to allow payment to be equitably captured and diverted from grow-
ers, processors, distributors, and consumers to compensate developers of the
novel germplasm.
Herbicide-resistant crops should enable growers to use more effective,
ecologically sound and economical herbicides than are currently at their
disposal. However, for such products to be effective in the marketplace, the
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grower must receive a tangible advantage through enhanced productivity and
decreased chemical expenditures. It is then reasonable to expect that a portion
of the financial savings seen by the grower would be shared with the provider
of the novel germplasm. This issue takes on still greater significance when
insect-resistant crops are considered. Herbicide resistance shifts farm input
expenditures from one chemical product to another, but insect resistance very
substantially reduces overall expenditures for purchased chemicals and thereby
generates much higher potential savings to the grower. The sharing of this
savings with germplasm developers can be accomplished through either pay-
ment of a premium on seed sales, or as a direct licensing payment to the
developer of the novel trait. However, such equitable value sharing is incon-
sistent with past industry practices that permit growers to save their own seed
for planting in subsequent years, a practice that would naturally limit compen-
sation delivered to those who initially created the novel germplasm. There are
now legal restrictions against the reuse of saved seed where the materials are
covered by utility patent claims, but industry acceptance must still be achieved.
If such compensation cannot be reliably returned to germplasm developers,
new cost-saving products will less likely become available to growers in the
years ahead.
FASTER PRODUCT DEVELOPMENT
Biotechnology will contribute to the streamlining of product development
cycles, or “cycle time,” in an industry where advancement has been generally
slow and methodical. Plant and animal traits, which in the past were objectives
of classical breeding programs, are already being generated in considerably
shorter time frames through the use of gene mapping and tracking. Where
formerly it may have been necessary to visually observe phenotypic traits in
populations of progeny following genetic crosses, it is becoming routine to
employ linked DNA markers to screen large numbers of progeny at an early
stage of development — even in seed prior to planting — thereby limiting
grow out to only the desired progeny. Analysis of the content of donor genome,
relative to the recipient, and selection of the most advanced progeny, enables a
more rapid introgression in far fewer breeding cycles. Thus, the rate of progress
in development of new germplasm has already accelerated, and commercial
products will become outdated more rapidly as replacements reach the market
in shorter time frames. The shortened product-life will necessitate more effec-
tive value-capture mechanisms than in the past.
The physical transfer of genes encoding new traits provides a very powerful
tool to further shorten the product development cycle. For example, in pro-
grams at Agracetus we have refined “gene gun” DNA delivery technology to
achieve delivery of genes directly into seed of commercial crop varieties. This
enables the direct germination of transgenic plants without the need for tissue
culture, thereby avoiding a process that both delays initial plant development
and limits gene transfer to only those varieties which can be managed in cul-
ture. Our first transgenic plants, in elite commercial varieties, reach maturity
within five months of project initiation and do not require time-consuming
back crossing. Because genes encoding new and desirable traits can readily be
moved across species boundaries, exceptionally diverse crop characteristics can
now be generated in a single growing season.
There are many potential advantages of such rapid product development,
but industry adaptation necessary to successfully manage these new capabilities
will be complex. This is exemplified in a second example, in which Agracetus
scientists have undertaken gene transfer programs to genetically engineer a
stronger cotton fiber, a trait that has historically been subject to premium pric-
ing and has been a long-term breeding target. The advantages of increased fiber
strength are found at various levels of the fiber industry, from processing steps
to consumer satisfaction. Stronger fiber is able to undergo more rapid pro-
cessing without breakage as the thread, yarn, and cloth are mechanically con-
structed, and the faster product through-put enabled by stronger fiber converts
to immediate savings on expensive capital equipment. In later processing steps,
where the chemical and mechanical processes used to “finish” fabrics weaken
fiber, a stronger fiber helps retain the durability characteristics that are valued
by consumers.
Through classical breeding, the average strength of cotton fiber across the
industry has been increasing at a relatively constant rate of 1.5 percent per year,
with a cumulative strength increase of 16 percent achieved from 1980 to 1991.
However, we are now able to use genetic engineering to dramatically increase
the strength of cotton fiber with the addition of genes from other organisms.
In our recent research project, the strength of the major upland cotton variety
was increased by more than 60 percent with a single transferred gene. This
represents a strength enhancement equivalent to 30 years of classical plant
breeding in a fraction of that time, and the fiber strength achieved now exceeds
the current premium system for fiber strength. Identity preservation of such
specialty fibers or an altered premium structure will therefore be needed if
exceptional value is to be captured. The industry has effectively adjusted to
incremental improvements in many characteristics such as fiber strength and
length, but must now consider the economic implications of more dramatic
quality changes in shorter time frames. In the fiber industry, and in many other
areas where crops are utilized, this will entail a more frequent evaluation of
processing technology to efficiently take advantage of new inputs. The capital
infrastructure for utilization of agriculture will need to become more flexible in
order to accept radically new and varied materials enabled by biotechnology.
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NEW PRODUCTS, NEW MARKETS
The ability to bring in new genes from different organisms further enables de-
velopment of novel agricultural products, including products that will extend
existing markets and those that will lead to entirely new business opportunities
for agriculture. A second cotton fiber concept from Agracetus offers one ex-
ample of a product that extends an existing agricultural product line. Our
intent in this program is to improve, beyond the capacity of existing cotton
germplasm, the dye-ability, chemical reactivity, absorbency, and structural
dynamics of fiber (such as shrinkage and wrinkle resistance). Already de-
veloped through this program are fibers that contain polyester in the fiber
core, and we have found that some of the more desirable characteristics of
petroleum-based synthetic fibers are imparted to the “natural” cotton fiber.
Similar programs to extend the current limits of materials derived from other
crops are underway in many other laboratories where oil, starch, and protein
alterations are being advanced beyond the capacity of existing germplasm. The
revision of plant products in this manner, by bringing in genetic information
from one organism to another, thus represents a broad opportunity to expand
current plant product markets. However, such new products will require sig-
nificant adjustment in processing practices and market structure to enable value
capture from traits not routinely monitored by the industry today. Sale of trans-
genic seed to growers at a premium price will not be sufficient, even as pro-
prietary protection becomes accepted, because the grower has no means to pass
on costs downstream to processors. The outcome will be an additional push
toward vertical integration, which will facilitate the channeling of identity-
preserved products from the field to dedicated processors, and then on to the
consumer.
The use of gene transfer between organisms also enables development of en-
tirely new agricultural uses, such as the Plant Bioreactor Program of Agracetus.
In this project, crops are used as production vessels to economically produce
large quantities of new biological materials. It has long been recognized that
plants provide the world’s most economical supply of proteins and complex
secondary metabolites, but historically the diversity and concentrations of
these materials were limited to what was found in nature or developed by man
through classical plant breeding. Gene transfer now enables the engineering
of crops to produce more of the valuable chemicals that are already found in
some species, and also new materials currently derived from other sources.
Targets of Plant Bioreactor Production include many high value biological
products destined for industrial, food, feed, and even pharmaceutical appli-
cation. Genetically engineered crops for each of those markets are currently
in development in a number of laboratories worldwide, and early product
candidates are already in field trials. Because the crops will require special
handling in the field, dedicated processing, and delivery to specific end-users,
vertical integration will clearly be a favored trend.
SUMMARY
Biotechnology represents a powerful new tool for plant and animal breeding,
and the application of this technology will lead to new products and new uses
for agriculture. This technology enables very rapid product development. The
increased speed of accomplishing genetic improvements also condenses product
development expense into much shorter time frames. These issues will neces-
sitate changes in industry practice to ensure that appropriate value can be
captured for the increased contribution of genetics as a component of final
product value. Historically, high quality genetics have been critical to agricul-
tural progress but have not fared well in capturing a significant portion of final
product value. Paper packaging now captures greater value than the grain in a
box of breakfast cereal. New paradigms for value capture will therefore evolve
to more equitably distribute value from consumers to those participants earlier
in the development path. The key industry changes to achieve this will be clari-
fication and enforcement of a strong system for intellectual property protection,
and vertical integration of the industry to coordinate value exchange from
germplasm provider to consumer. While the most exciting aspect of bio-
technology application to agriculture will be novel products and new uses
for crops, even commodity agriculture will be affected by broad changes in
industry management of crop value.
Barton
